Drugs for HER-2-positive breast cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
| Publicado no: | Springer eBooks. |
|---|---|
| Autor Corporativo: | |
| Outros Autores: | , , , |
| Formato: | Electronic Resource |
| Idioma: | inglês |
| Publicado em: |
Basel
Springer Basel
c2011.
|
| Assuntos: | |
| Acesso em linha: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |